Search the Newsreel

BrainsWay: Market Saturation And Competition Could Be Issues (NASDAQ:BWAY)

BrainsWay delivered strong Q2 financial results with 35% YoY revenue growth and margin expansion, fueled by market expansion. However, the company's valuation is considered high, raising concerns about future competition from psychedelics and potential market saturation. While near-term momentum is possible, sustained long-term growth …

Earnings call transcript: BrainsWay tops revenue forecasts in q2 2026

BrainsWay Ltd. reported strong second-quarter 2026 results, exceeding revenue forecasts with $17.1 million and matching adjusted EPS expectations at $0.07. The company raised its full-year 2026 revenue guidance to $68 million-$70 million, driven by strong demand for its Deep TMS systems and SWIFT accelerated …

Brainsway Q2 Earnings Call Highlights

Key Points Interested in Brainsway Ltd. Sponsored ADR? Here are five stocks we like better. BrainsWay reported strong Q2 results, with revenue up 35% to $17.1 million, adjusted EBITDA up 141% to $3.5 million, and its 12th consecutive profitable quarter. The company shipped 125 …

Brainsway (NASDAQ:BWAY) Reaches New 12-Month High After Strong Earnings

BrainsWay (NASDAQ: BWAY) boosts 2026 guidance after 35% jump in Q2 revenue

BrainsWay (NASDAQ: BWAY) reported strong Q2 2026 financial results with a 35% year-over-year revenue increase to $17.1 million and Adjusted EBITDA more than doubling to $3.5 million. The company shipped a record 125 Deep TMS systems, expanding its installed base, and generated $6.3 million …

BrainsWay (BWAY) shows 35% revenue growth, 75% gross margin and rising backlog

Brainsway (NASDAQ:BWAY) Stock Price Up 13% on Analyst Upgrade

Brainsway stock price target raised to $20 by BTIG on revenue beat

Brainsway (NASDAQ:BWAY) Posts Earnings Results, Misses Estimates By $0.03 EPS

BrainsWay Releases Q2 2026 Financial Results

BrainsWay Ltd. (BWAY) reported Q2 2026 financial results, meeting profit expectations with diluted EPS of $0.07 and beating revenue estimates with $17.1M. The company's Deep TMS technology drove a 35% revenue surge year-over-year, shipping 125 systems in the quarter, and set full-year revenue guidance …

Brainsway earnings matched, revenue topped estimates

Earnings To Watch: BrainsWay Ltd (BWAY) Q2 2026 -- GF Value Sees 35% Downside

BrainsWay Ltd (BWAY) is scheduled to release its Q2 2026 earnings on August 12, 2026, with consensus estimates predicting revenues of $16.55 million and earnings of $0.07 per share. While analysts forecast an average target price of $17.67, implying a 15.32% upside, GuruFocus estimates …

Brainsway Ltd expected to post earnings of 7 cents a share - Earnings Preview

Brainsway Ltd is expected to report earnings of 7 cents per share, according to a Reuters earnings preview available on TradingView. The article title serves as the primary information, with further details behind a paywall.

Brainsway Ltd (BWAY) Stock News Today

This page on TradingKey provides current stock news for Brainsway Ltd (BWAY), a company in the Healthcare Equipment & Supplies sector. As of the closing bell on August 7th, BWAY was trading at $15.500, down 0.96%. The page indicates that more news will be …

Brainsway Ltd (BWAY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Brainsway Ltd (BWAY), highlighting its strong earnings forecast score and analyst ratings. The average price target for BWAY is $23.50, with analysts largely recommending a "Strong Buy." The report also details past and projected EPS and revenue …

Earnings Preview: Brainsway to Report Financial Results Pre-market on August 12

Brainsway (BWAY.US) is scheduled to release its financial results pre-market on August 12 ET. Analysts estimate the company to report Q2 2026 revenue of USD16.54 million, a 30.95% year-over-year increase, with EPS estimated at USD0.073, up 193.2% year-over-year. The accounting standard used for these …

BrainsWay: Building A Capital-Light Interventional Psychiatry Ecosystem

Renaissance Technologies LLC Buys 241,560 Shares of Brainsway Ltd. Sponsored ADR $BWAY

Renaissance Technologies LLC significantly increased its stake in Brainsway Ltd. Sponsored ADR (BWAY) during the first quarter by purchasing an additional 241,560 shares, bringing its total holdings to 518,420 shares valued at approximately $6.89 million. Other institutional investors also expanded their positions, contributing to …

Brainsway (BWAY) Expected to Announce Earnings on Wednesday

Brainsway (NASDAQ:BWAY) is projected to release its Q2 2026 earnings before market open on Wednesday, August 12th. Analysts anticipate earnings of $0.10 per share and revenues of $16.54 million, with the earnings call scheduled for August 13th. The company surpassed expectations in the previous …

(BWAY) Volatility Zones as Tactical Triggers

The article analyzes Brainsway Ltd. (NASDAQ: BWAY) using AI models, identifying a neutral near-term sentiment with resistance being tested. It presents three trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, noting an exceptional 78.8:1 risk-reward short setup.

Brainsway (NASDAQ:BWAY) Upgraded at Wall Street Zen

Wall Street Zen upgraded Brainsway (NASDAQ:BWAY) from a "hold" to a "buy" rating, reflecting a generally positive sentiment among analysts, with a consensus "Buy" rating and an average price target of $15.67. The company recently surpassed earnings expectations, reporting $0.12 EPS against a $0.05 …

BWAY|Brainsway Ltd|Price:15.220|Chg%:+1.060

TradingKey's stock analysis of Brainsway Ltd (BWAY) indicates strong fundamentals and high growth potential, with revenue increasing by an average of 64.31% over the past three years. The company is considered fairly valued and has a high institutional ownership, with multiple analysts rating it …

BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026

BrainsWay Ltd. will report its second quarter 2026 financial results and operational highlights on Wednesday, August 12, 2026, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide …

BrainsWay schedules business operations update for Aug. 12 webcast

BrainsWay (NASDAQ & TASE: BWAY) announced it will report its second quarter 2026 financial results and operational highlights before the U.S. market opens on Wednesday, August 12, 2026. The company will host an English conference call and webcast at 8:30 AM Eastern Time to …

Harel Insurance (BWAY) reports 3.27M-share beneficial stake in Brainsway

Harel Insurance Investments & Financial Services Ltd. has reported a beneficial ownership of 3,265,397 Ordinary Shares in Brainsway Ltd. (BWAY), which constitutes 8.3% of the company's outstanding shares. The majority of these shares are held on behalf of public investors through various funds and …

Brainsway Ltd Revenue Breakdown – TASE:BWAY

This article provides a revenue breakdown for Brainsway Ltd (TASE:BWAY), highlighting that the United States is its largest contributing region. In the past year, the U.S. accounted for 152.52 million ILS in revenue, an increase from 123.00 million ILS the previous year. The data …

Brainsway Ltd. Sponsored ADR $BWAY Stock Position Raised by Masters Capital Management LLC

Masters Capital Management LLC significantly increased its stake in Brainsway Ltd. Sponsored ADR (BWAY) by 65% in the first quarter, now owning 1.65 million shares. The medical device company exceeded Q1 earnings estimates, reporting $0.12 per share versus $0.05 anticipated, and surpassed revenue expectations …

Brainsway Ltd (BWAY) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Brainsway Ltd (BWAY) stock, focusing on its dividend history and planned stock splits. It notes that no dividends have been distributed in the past five years and highlights a 1-for-2 stock split scheduled for February 17, 2026. Current …

BrainsWay Market Sentiment

This article provides an overview of BrainsWay (BWAY) market sentiment, including analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" analyst consensus with 5 analysts, a low short interest of 0.6%, and bullish options flow, indicating a positive market outlook …

Brainsway Ltd|Price:15.970|Chg%:-0.540

Brainsway Ltd (BWAY) is an Israel-based company specializing in medical devices for neurological and psychopathological disorders. The company's primary product is the Transcranial Magnetic Stimulation (TMS) system, which non-invasively stimulates deep brain structures for various clinical applications, including major depressive disorders and obsessive-compulsive disorder. …

Zacks Names Brainsway (NASDAQ: BWAY) Bull Of The Day While Lululemon (NASDAQ: LULU) Earns Bear Designation

Zacks Equity Research has named Brainsway (NASDAQ: BWAY) its Bull of the Day due to strong revenue growth, expanding insurance coverage for its Deep TMS therapy, and a positive outlook for future earnings. Conversely, Lululemon (NASDAQ: LULU) received the Bear of the Day designation …

Brainsway Ltd (BWAY) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Brainsway Ltd (BWAY), indicating a current valuation score of 5.10, ranking it 192 out of 200 in the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio of 34.82, noting its position relative to …

H.C. Wainwright Maintains Brainsway(BWAY.US) With Buy Rating, Maintains Target Price $17

H.C. Wainwright has reiterated its Buy rating for Brainsway (BWAY.US), maintaining a target price of $17. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance and valuation. The decision reflects confidence in Brainsway's financial prospects and market position.